The sources told that the Pune-based drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials of 'Covidshield'.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ZY36dX
via IFTTT
Serum Institute of India seeks DCGI permission for phase 2/3 clinical trials of Oxford's COVID 'vaccine'
The sources told that the Pune-based drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials of 'Covidshield'.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2ZY36dX
via IFTTT
0 comments:
Post a Comment